Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 1431Pancreatic Neoplasms 664Colonic Neoplasms 655Carcinoma, Hepatocellular 632Rectal Neoplasms 571Stomach Neoplasms 547Esophageal Neoplasms 384Liver Neoplasms 280Breast Neoplasms 278Neoplasms 243Gastrointestinal Neoplasms 214Lung Neoplasms 175Prostatic Neoplasms 137Barrett Esophagus 127Colonic Polyps 115Cholangiocarcinoma 114Motor Activity 101Ovarian Neoplasms 75Head and Neck Neoplasms 73Neoplasm Metastasis 64Adenoma 61Uterine Cervical Neoplasms 58Anus Neoplasms 54Anastomotic Leak 54Carcinoma, Non-Small-Cell Lung 53Colorectal Neoplasms, Hereditary Nonpolyposis 51Biliary Tract Neoplasms 51Postoperative Complications 49Urinary Bladder Neoplasms 47Esophageal Squamous Cell Carcinoma 47

Interventions

zirconium-89-trastuzumab 1Positron-Emission Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Esophagogastric Cancer × Gastrointestinal × Clear all
NCT05796102 2026-03-05

PET-MRI

University Health Network, Toronto

Phase NA Recruiting
15 enrolled
Gastrointestinal

Esophagogastric Cancer

NCT02023996 2024-12-10

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Completed
42 enrolled 11 charts
Gastrointestinal

Esophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡